Leupin Nicolas 4
4 · NovoCure Ltd · Filed Mar 6, 2025
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Leupin Nicolas
Former Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2025-03-04$18.19/sh+81,499$1,482,467→ 81,499 totalExercise: $18.19From: 2026-03-04Exp: 2035-03-03→ Ordinary Shares (81,499 underlying) - Award
Ordinary Shares
2025-03-04$18.19/sh+54,975$999,995→ 105,108 total
Footnotes (2)
- [F1]Represents restricted share units that are scheduled to vest in equal installments on March 4, 2026, 2027 and 2028, subject to the reporting person's continued employment through such dates.
- [F2]Options to buy 81,499 ordinary shares will vest in equal installments on each of March 4, 2026, 2027, 2028 and 2029, subject to the reporting person's continued employment through such dates.